[SGMO] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
28-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -10.95%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 111,299 110,701 118,192 102,428 84,452 36,567 19,389 33.79%
PBT -191,849 -177,991 -120,777 -95,419 -68,889 -54,568 -71,672 17.82%
Tax 429 306 345 -19,601 8,261 -1,498 -14 -
NP -192,278 -178,297 -121,122 -75,818 -68,334 -54,568 -71,658 17.87%
Tax Rate - - - - - - - -
Total Cost 303,577 288,998 239,314 178,246 152,786 91,135 91,047 22.21%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -172.76 -161.06 -102.48 -74.02 -80.91 -149.23 -369.58 -11.89%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.25 -1.23 -0.90 -0.68 -0.70 -0.70 -1.02 3.44%
EPS Diluted -1.25 -1.23 -0.90 -0.68 -0.70 -0.70 -1.02 3.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.